Table 3 Multivariable analysis resultsa.
Number | Relative risk | 95% CI lower limit | 95% CI upper limit | p-value | Overall p-value | |
---|---|---|---|---|---|---|
Non-relapse mortality | ||||||
2000–2005 | 76 | 1.00 | 0.40 | |||
2006–2010 | 238 | 0.80 | 0.51 | 1.24 | 0.32 | |
2011–2015 | 413 | 0.74 | 0.48 | 1.15 | 0.18 | |
Progression/relapse | ||||||
2000–2005 | 76 | 1.00 | 0.48 | |||
2006–2010 | 238 | 0.77 | 0.51 | 1.17 | 0.22 | |
2011–2015 | 413 | 0.82 | 0.54 | 1.24 | 0.34 | |
Progression-free survival | ||||||
2000–2005 | 76 | 1.00 | 0.54 | |||
2006–2010 | 238 | 0.84 | 0.60 | 1.15 | 0.27 | |
2011–2015 | 413 | 0.85 | 0.61 | 1.18 | 0.32 | |
Overall survival | ||||||
2000–2005 | 76 | 1.00 | 0.055 | |||
2006–2010 | 238 | 0.753 | 0.545 | 1.04 | 0.09 | |
2011–2015 | 413 | 0.667 | 0.479 | 0.929 | 0.02 |